(LSK7) Lyxor Stoxx 50 Daily Short - Ratings and Ratios
Inverse Equity, Leveraged ETF, Short Strategy, Tracking Stoxx 50
Description: LSK7 Lyxor Stoxx 50 Daily Short
The Lyxor UCITS Stoxx50 Daily Short ETF (XETRA:LSK7) is an exchange-traded fund designed to provide inverse exposure to the EURO STOXX 50 Index, meaning it is intended to perform well when the underlying index declines. This ETF is particularly suited for investors seeking to hedge against potential downturns in the European blue-chip market or speculate on declines in the index.
From a technical standpoint, the ETFs price action indicates a bearish trend, as it is currently trading below its short-term, medium-term, and long-term Simple Moving Averages (SMA20, SMA50, SMA200). The Average True Range (ATR) of 0.16, representing 2.07% of the last price, suggests relatively moderate volatility. The fact that the ETF is trading near its 52-week low of 7.74 may indicate a level of support, but it also reflects the overall bearish sentiment. Given the technical indicators, a potential trading strategy could involve monitoring the ETFs ability to break above the SMA20 or SMA50 levels, which could signal a potential reversal or a lessening of the bearish trend.
Fundamentally, the Assets Under Management (AUM) of 44.20M EUR indicate a relatively modest size for the ETF, which could impact liquidity. However, being listed on XETRA, a major European exchange, still provides a reasonable level of accessibility and visibility for investors. The funds management and operational aspects, such as fees and tracking efficiency, should be scrutinized by potential investors, as these factors can significantly affect the ETFs performance relative to its inverse objective.
Forecasting the ETFs future performance involves considering both the technical and fundamental aspects. Technically, a break above the SMA20 (8.08) could be a bullish signal, potentially leading to further gains towards the SMA50 (8.23). Fundamentally, the direction of the EURO STOXX 50 Index will be crucial. If the index is expected to decline due to economic downturns or other factors, LSK7 could potentially benefit. Conversely, if the index is poised for growth, LSK7s inverse nature means it is likely to decline. Therefore, a forecast would need to heavily rely on the outlook for the EURO STOXX 50 Index, as well as technical analysis of LSK7s price movements and trends.
Given the current technical and fundamental data, a cautious approach might be warranted. Investors should closely monitor the ETFs price action relative to its moving averages and the overall trend of the EURO STOXX 50 Index. A strategic decision to invest in LSK7 would depend on a thorough analysis of market conditions, the investors risk tolerance, and their investment goals, particularly if they are looking to hedge against or speculate on declines in the European blue-chip market.
Additional Sources for LSK7 ETF
LSK7 ETF Overview
Market Cap in USD | 52m |
Category | Trading - Leveraged/Inverse Equity |
TER | 0.40% |
IPO / Inception | 2007-04-03 |
LSK7 ETF Ratings
Growth Rating | -72.2 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -30.4 |
Analysts | - |
Fair Price Momentum | 6.71 EUR |
Fair Price DCF | - |
LSK7 Dividends
Currently no dividends paidLSK7 Growth Ratios
Growth Correlation 3m | -44.7% |
Growth Correlation 12m | -70.6% |
Growth Correlation 5y | -93.4% |
CAGR 5y | -12.81% |
CAGR/Max DD 5y | -0.24 |
Sharpe Ratio 12m | -1.64 |
Alpha | -8.82 |
Beta | -0.619 |
Volatility | 12.92% |
Current Volume | 2.9k |
Average Volume 20d | 4.7k |
Stop Loss | 7.5 (-3.6%) |
As of July 12, 2025, the stock is trading at EUR 7.78 with a total of 2,892 shares traded.
Over the past week, the price has changed by -1.83%, over one month by -0.38%, over three months by -12.63% and over the past year by -8.67%.
No, based on ValueRay´s Analyses, Lyxor Stoxx 50 Daily Short (XETRA:LSK7) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -72.21 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LSK7 is around 6.71 EUR . This means that LSK7 is currently overvalued and has a potential downside of -13.75%.
Lyxor Stoxx 50 Daily Short has no consensus analysts rating.
According to our own proprietary Forecast Model, LSK7 Lyxor Stoxx 50 Daily Short will be worth about 7.2 in July 2026. The stock is currently trading at 7.78. This means that the stock has a potential downside of -6.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.2 | -6.9% |